FAG
TNDM icon

Fortitude Advisory Group’s Tandem Diabetes Care TNDM Stock Holding History

Fortitude Advisory Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-148
Closed -$17K – 1187
2022
Q1 		$17K Hold
148
– – 0.01% 889
2021
Q4 		$22K Buy
+148
New +$20K 0.01% 819

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fortitude Advisory Group's TNDM Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 148 shares — an estimated $17K sold.

Fortitude Advisory Group first reported a position in TNDM in Q4 2021 and held it in 2 quarters. The position peaked at $22K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Fortitude Advisory Group reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 148 Tandem Diabetes Care shares in Q2 2022, an estimated $17K.
  • Fortitude Advisory Group first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's Tandem Diabetes Care position peaked at $22K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.